Research location
Durham
United Kingdom
Advertisement
Research activity in Durham
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 29 trials and 30 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Durham
29 linked trials · page 1 of 1Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary DiseaseNCT06347536 · 2025-01-30 · 1 site observation
RECRUITING
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsNCT06008197 · 2024-01-17 · 1 site observation
RECRUITING
Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph NodesNCT04500262 · 2020-07-13 · 1 site observation
UNKNOWN
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)NCT03876015 · 2019-05-01 · 1 site observation
COMPLETED
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.NCT03330847 · 2018-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)NCT02574455 · 2017-11-07 · 1 site observation
COMPLETED
Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)NCT03269110 · 2017-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)NCT02585778 · 2015-10-23 · 1 site observation
COMPLETED
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic GastroparesisNCT02357420 · 2015-01-29 · 1 site observation
COMPLETED
Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes MellitusNCT02284009 · 2014-10-10 · 1 site observation
COMPLETED
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerNCT01992952 · 2014-05-07 · 1 site observation
ACTIVE_NOT_RECRUITING
An Evaluation of a Novel Glucose Sensing Technology in Type 2 DiabetesNCT02082184 · 2014-03-01 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerNCT02216786 · 2014-01-16 · 1 site observation
COMPLETED
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesNCT01836523 · 2013-11-01 · 1 site observation
COMPLETED
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateNCT01764997 · 2013-04-01 · 2 site observations
TERMINATED
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsNCT01768559 · 2013-01-01 · 1 site observation
COMPLETED
Sensor and Software Use for Improved Glucose Control in MDI Managed DiabetesNCT01713348 · 2012-10-01 · 1 site observation
COMPLETED
A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid ArthritisNCT01640548 · 2012-09-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerNCT01572038 · 2012-06-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)NCT01483560 · 2011-12-01 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeNCT01228682 · 2010-10-01 · 1 site observation
UNKNOWN
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)NCT01026142 · 2010-01-26 · 1 site observation
COMPLETED
Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsNCT00965549 · 2009-07-01 · 1 site observation
COMPLETED
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-InhibitorNCT01557348 · 2009-06-01 · 1 site observation
COMPLETED
Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.